Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
32

EW
Edwards Lifesciences

Last Price:
66.75
Seasonality Move:
11.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Edwards Lifesciences Price Quote

$66.75
+0.23 (+0.35%)
(Updated: November 14, 2024 at 12:35 PM ET)

Edwards Lifesciences Key Stats

Sell
32
Edwards Lifesciences (EW) is a Sell

Day range:
$65.31 - $66.89
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
28.61
P/S ratio:
6.02
P/B ratio:
4.07%

Volume:
3.5M
Avg. volume:
5.2M
1-year change:
2.97%
Market cap:
$38.8B
Revenue:
$6B
EPS:
$6.93

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 7.14%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $806.4M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.4B
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $2.9B

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 51.05%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 40.35%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 55.09%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

Edwards Lifesciences Dividend Yield

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: 714.29% 13.97%
Revenue: 8.93% -1.01%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 19
Sell Recommendations: 0
Price Target: 76.39
Upside from Last Price: 14.84%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    771.4M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.8M EW shares are owned by insiders